GSK (GSK) return on equity (ROE)

Return on equity · fiscal 2025
34.9%

GSK earned a return on equity of 34.9% in fiscal 2025 (the year ended December 31, 2025). That is 16.1 percentage points higher than the 18.8% of fiscal 2024. Figures as of 17 Nov 2026, 21:32 UTC, from Yahoo Finance.

Key facts

Return on equity, fiscal 2025
34.9%
Change on fiscal 2024
+16.1 pts
Highest on record
141.1%fiscal 2022
Lowest on record
18.8%fiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

GSK return on equity (ROE), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 141.1% in fiscal 2022 and the lowest 18.8% in fiscal 2024. The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 36.9%.

History · 4 fiscal years

Return on equity by fiscal year

GSK return on equity (ROE), year by year

GSK (GSK) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202534.9% 16.1 pts up
202418.8% 18.1 pts down
202336.9% 104.2 pts down
2022141.1%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of GSK and comparable companies
CompanyReturn on equityFiscal year
Sanofi SNY10.9%2025
Moderna MRNA-32.6%2025
CVS Health CVS2.4%2025
HCA Healthcare HCA656.3%2020
GSK GSK34.9%2025
Regeneron Pharmaceuticals REGN14.4%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GSK

GSK, figure by figure

GSK (GSK) overview: price, valuation and scorecardAll health care companies by market value

GSK return on equity (ROE): questions and answers

What is GSK's return on equity?

GSK earned a return on equity of 34.9% in fiscal 2025 (the year ended December 31, 2025). That is 16.1 percentage points higher than the 18.8% of fiscal 2024.

Is GSK's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 36.9%.

What are the highest and lowest return on equity figures on record for GSK?

Across the 4 fiscal years on record (2022–2025), the highest was 141.1% in fiscal 2022 and the lowest 18.8% in fiscal 2024.

How is GSK's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “GSK (GSK) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/GSK/roe

Underlying data: Yahoo Finance.